US legislators call for screws to be tightened on pharma patent strategies
New report issued by Democrats in the House of Representatives indicates a change of tack in approaching potential reforms may be on the cards
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.